Working… Menu

Non-operative Management of Pediatric Appendicitis With an Appendicoltih

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02189668
Recruitment Status : Terminated (High failure rate)
First Posted : July 14, 2014
Results First Posted : April 17, 2018
Last Update Posted : November 27, 2018
Information provided by (Responsible Party):
Peter Minneci, Nationwide Children's Hospital

Brief Summary:
To determine if non-operative management with antibiotics alone is a feasible treatment alternative for pediatric patients with uncomplicated acute appendicitis with an appendicolith identified on imaging.

Condition or disease Intervention/treatment Phase
Appendicitis Drug: Antibiotics only (Zosyn then Augmentin) Not Applicable

Detailed Description:
This study is a prospective randomized clinical trial comparing non-operative management with antibiotics to urgent appendectomy in children (ages 7-17yrs) with acute appendicitis with the presence of an appendicolith. Enrolled participants were followed up to 1 year post-discharge to observe the rates of appendicitis recurrence as well as identify the number of patients with complicated appendicitis as determined by pathologic examination.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 14 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Non-operative Management of Uncomplicated Appendicitis With an Appendicolth in Children
Study Start Date : July 2014
Actual Primary Completion Date : July 2015
Actual Study Completion Date : July 2015

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Non-operative Management
Non-operative management with antibiotics only Zosyn (Piperacillin/Tazobactam) and then Augmentin unless penicillin allergic Cipro/Flagyl if penicillin allergic
Drug: Antibiotics only (Zosyn then Augmentin)
Intravenous and oral antibiotics without surgery Piperacillin/Tazobactam and then Augmentin Cipro/Flagyl if Penicillin allergic
Other Name: non operative management

No Intervention: Surgery
Usual care with urgent appendectomy

Primary Outcome Measures :
  1. Number of Participants That Did Not Have an Appendectomy [ Time Frame: 1 year ]
    Percentage of patients who were successfully managed nonoperatively with success defined as not undergoing appendectomy by one year after discharge

Secondary Outcome Measures :
  1. Number of Participants With Complicated Appendicitis [ Time Frame: 1 year ]
    Percent of patients found to have complicated appendicitis (gangrenous or perforated) on pathologic examination.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   7 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age : 7-17 years
  • Abdominal pain </= 48hours prior to receiving antibiotics
  • White Blood Cell Count >5 but < 18
  • US or CT confirmed early appendicitis plus:

    • US: </=1.1 cm in diameter, presence of appendicolith
    • CT: </= 1.1cm in diameter, presence of appendicolith

Exclusion Criteria:

  • Positive urine pregnancy test
  • Pain > 48 hours prior to first antibiotic dose
  • Diffuse peritonitis
  • History of chronic intermittent abdominal pain
  • White Blood Cell count ≤ 5 or ≥ 18
  • Absence of appendicolith or any evidence on imaging studies concerning for evolving perforated appendicitis including abscess or phlegmon

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02189668

Layout table for location information
United States, Ohio
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205
Sponsors and Collaborators
Peter Minneci
Layout table for investigator information
Principal Investigator: Peter C Minneci, MD Nationwide Children's Hospital
Publications of Results:
Other Publications:
Layout table for additonal information
Responsible Party: Peter Minneci, Principal Investigator, Nationwide Children's Hospital Identifier: NCT02189668    
Other Study ID Numbers: IRB14-00218
First Posted: July 14, 2014    Key Record Dates
Results First Posted: April 17, 2018
Last Update Posted: November 27, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Peter Minneci, Nationwide Children's Hospital:
Additional relevant MeSH terms:
Layout table for MeSH terms
Intraabdominal Infections
Gastrointestinal Diseases
Digestive System Diseases
Cecal Diseases
Intestinal Diseases
Anti-Bacterial Agents
Amoxicillin-Potassium Clavulanate Combination
Anti-Infective Agents
beta-Lactamase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action